FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211797277> ?p ?o ?g. }

• W3211797277 endingPage "677" @default.
• W3211797277 startingPage "673" @default.
• W3211797277 abstract "Pharmaceutical inventions may be defined as inventions that have effect on humans for medical purposes, whether they prevent or heal diseases or for other purposes. The patent as a subjective right can belong to a person or a legal authority, to a territory and for a certain time, and the holder of the patent rights have an exclusive right to the protected invention, to use and exploit the material and moral values for the duration of the patent protection. The Intellectual property Law recognizes the granting of patents for inventions of drugs, in terms of Article 27(1) of the TRIPS. When the patent for an invention of a drug is granted, its holder is authorized to undertake certain exclusive entitlements and to claim such exclusivity relating to third parties (Article 28 of the TRIPS). A patent is a recognition for an invention, which satisfies the criteria of global novelty, non-obviousness, and industrial application. These legal rights confer an exclusive right to the inventor or his assignee to fully utilize his invention for a given period of time. It is very well settled that IPRs play a vital role in the modern economy. IPR is a strong tool established to protect investments in time, money and effort invested by the drug inventor since it grants the inventor an exclusive right to use his invention/creation for a certain period of time. Thus IPRs, in this way aid the economic development of a country by promoting healthy competition and by encouraging industrial development and economic growth.The protection of inventions with patents in the pharmaceutical industry has a specific role in the development of society and represents one of the drivers in economic development. The investments in research and development of a novel chemical or biologic medicine are encouraged and awarded by granting a patent, which is associated with building a reliable and efficient system regarding innovation and research incentives. Biological products are complex molecules, produced by living cells, that are naturally produced in the human body, or monoclonal antibodies, but also blood products, immunological medicinal products, sera and vaccines, allergens, and advanced technology products such as gene and cell therapy products. Copies of these products, known as biosimilars are not identical, so specific regulatory issues are required for licencing and for placing them in the market. The licensing of biosimilars is usually based on a very robust registration process, to demonstrate efficacy and safety profile and to ensure that the biosimilar is highly similar to the original biological product. Biosimilars can be placed in the market only after IPRs and other exclusivities of the original biological product are no longer valid. It is very important for biosimilar developers to fully understand the patent terms and their longevity, to avoid any patent disputes and patent litigation." @default.
• W3211797277 created "2021-11-22" @default.
• W3211797277 creator A5014810738 @default.
• W3211797277 creator A5045305172 @default.
• W3211797277 date "2021-06-15" @default.
• W3211797277 modified "2023-09-23" @default.
• W3211797277 title "INTELLECTUAL PROPERTY RIGHTS FOR BIOSIMILAR MEDICINAL PRODUCTS" @default.
• W3211797277 hasPublicationYear "2021" @default.
• W3211797277 type Work @default.
• W3211797277 sameAs 3211797277 @default.
• W3211797277 citedByCount "0" @default.
• W3211797277 crossrefType "journal-article" @default.
• W3211797277 hasAuthorship W3211797277A5014810738 @default.
• W3211797277 hasAuthorship W3211797277A5045305172 @default.
• W3211797277 hasConcept C127413603 @default.
• W3211797277 hasConcept C138885662 @default.
• W3211797277 hasConcept C144133560 @default.
• W3211797277 hasConcept C150903083 @default.
• W3211797277 hasConcept C157085824 @default.
• W3211797277 hasConcept C162324750 @default.
• W3211797277 hasConcept C165696696 @default.
• W3211797277 hasConcept C17744445 @default.
• W3211797277 hasConcept C18903297 @default.
• W3211797277 hasConcept C190253527 @default.
• W3211797277 hasConcept C199539241 @default.
• W3211797277 hasConcept C21442874 @default.
• W3211797277 hasConcept C22212356 @default.
• W3211797277 hasConcept C27206212 @default.
• W3211797277 hasConcept C2777029862 @default.
• W3211797277 hasConcept C2778738651 @default.
• W3211797277 hasConcept C2779541081 @default.
• W3211797277 hasConcept C2780454388 @default.
• W3211797277 hasConcept C2780697943 @default.
• W3211797277 hasConcept C2984145337 @default.
• W3211797277 hasConcept C34974158 @default.
• W3211797277 hasConcept C38652104 @default.
• W3211797277 hasConcept C41008148 @default.
• W3211797277 hasConcept C59491497 @default.
• W3211797277 hasConcept C74676461 @default.
• W3211797277 hasConcept C86803240 @default.
• W3211797277 hasConcept C91306197 @default.
• W3211797277 hasConceptScore W3211797277C127413603 @default.
• W3211797277 hasConceptScore W3211797277C138885662 @default.
• W3211797277 hasConceptScore W3211797277C144133560 @default.
• W3211797277 hasConceptScore W3211797277C150903083 @default.
• W3211797277 hasConceptScore W3211797277C157085824 @default.
• W3211797277 hasConceptScore W3211797277C162324750 @default.
• W3211797277 hasConceptScore W3211797277C165696696 @default.
• W3211797277 hasConceptScore W3211797277C17744445 @default.
• W3211797277 hasConceptScore W3211797277C18903297 @default.
• W3211797277 hasConceptScore W3211797277C190253527 @default.
• W3211797277 hasConceptScore W3211797277C199539241 @default.
• W3211797277 hasConceptScore W3211797277C21442874 @default.
• W3211797277 hasConceptScore W3211797277C22212356 @default.
• W3211797277 hasConceptScore W3211797277C27206212 @default.
• W3211797277 hasConceptScore W3211797277C2777029862 @default.
• W3211797277 hasConceptScore W3211797277C2778738651 @default.
• W3211797277 hasConceptScore W3211797277C2779541081 @default.
• W3211797277 hasConceptScore W3211797277C2780454388 @default.
• W3211797277 hasConceptScore W3211797277C2780697943 @default.
• W3211797277 hasConceptScore W3211797277C2984145337 @default.
• W3211797277 hasConceptScore W3211797277C34974158 @default.
• W3211797277 hasConceptScore W3211797277C38652104 @default.
• W3211797277 hasConceptScore W3211797277C41008148 @default.
• W3211797277 hasConceptScore W3211797277C59491497 @default.
• W3211797277 hasConceptScore W3211797277C74676461 @default.
• W3211797277 hasConceptScore W3211797277C86803240 @default.
• W3211797277 hasConceptScore W3211797277C91306197 @default.
• W3211797277 hasIssue "4" @default.
• W3211797277 hasLocation W32117972771 @default.
• W3211797277 hasOpenAccess W3211797277 @default.
• W3211797277 hasPrimaryLocation W32117972771 @default.
• W3211797277 hasRelatedWork W1549393675 @default.
• W3211797277 hasRelatedWork W158415122 @default.
• W3211797277 hasRelatedWork W1932766415 @default.
• W3211797277 hasRelatedWork W1987070377 @default.
• W3211797277 hasRelatedWork W2066126534 @default.
• W3211797277 hasRelatedWork W2111687551 @default.
• W3211797277 hasRelatedWork W2133704321 @default.
• W3211797277 hasRelatedWork W2252280539 @default.
• W3211797277 hasRelatedWork W2612765030 @default.
• W3211797277 hasRelatedWork W2734612042 @default.
• W3211797277 hasRelatedWork W2895078957 @default.
• W3211797277 hasRelatedWork W2899782378 @default.
• W3211797277 hasRelatedWork W2923777707 @default.
• W3211797277 hasRelatedWork W2964518728 @default.
• W3211797277 hasRelatedWork W3014351019 @default.
• W3211797277 hasRelatedWork W3123385814 @default.
• W3211797277 hasRelatedWork W3124574819 @default.
• W3211797277 hasRelatedWork W3149937332 @default.
• W3211797277 hasRelatedWork W772658997 @default.
• W3211797277 hasRelatedWork W2585365496 @default.
• W3211797277 hasVolume "46" @default.
• W3211797277 isParatext "false" @default.
• W3211797277 isRetracted "false" @default.
• W3211797277 magId "3211797277" @default.
• W3211797277 workType "article" @default.